Prediction performance of machine-learning algorithms: 12-month survival
Cancer type | Area under ROC curve (95% CI) | ||
---|---|---|---|
EAR only | ECO only | EAR+ECO | |
Genitourinary | 0.79 (0.75 to 0.83) | 0.79 (0.75 to 0.83) | 0.84 (0.80 to 0.87)*,† |
Colorectal | 0.82 (0.78 to 0.86) | 0.83 (0.79 to 0.86) | 0.87 (0.83 to 0.90)*,† |
Lung | 0.73 (0.69 to 0.77) | 0.78 (0.73 to 0.82)* | 0.82 (0.78 to 0.86)*,† |
Breast | 0.71 (0.65 to 0.78) | 0.90 (0.86 to 0.94) | 0.92 (0.89 to 0.96)* |
Haematological | 0.63 (0.59 to 0.68) | 0.70 (0.66 to 0.75)* | 0.69 (0.64 to 0.74)* |
Upper gastrointestinal | 0.62 (0.57 to 0.66) | 0.70 (0.65 to 0.74)* | 0.72 (0.68 to 0.76)* |
Skin | 0.76 (0.71 to 0.88) | 0.89 (0.85 to 0.93)* | 0.93 (0.90 to 0.96)* |
Head and neck | 0.77 (0.73 to 0.88) | 0.68 (0.63 to 0.73) | 0.79 (0.75 to 0.84)† |
Gynaecological | 0.95 (0.92 to 0.97) | 1 (1 to 1)* | 0.99 (0.98 to 1)* |
CNS | 0.66 (0.58 to 0.73) | 0.68 (0.61 to 0.76) | 0.69 (0.63 to 0.76) |
Unknown primary | 0.87 (0.84 to 0.91) | 0.81 (0.77 to 0.85) | 0.88 (0.84 to 0.91) |
*Significantly greater than EAR only.
†Significantly greater than ECO only.
CNS, central nervous system; EAR, electronic administrative records; ECO, Evaluation of Cancer Outcomes; ROC, receiver operating characteristic.